Old stuff still trending: use of propafenone as a safety net until catheter ablation in a patient with documented pre-excited atrial fibrillation and Wolff-Parkinson-White syndrome - a classic case report.
Dimitrios KarelasJohn PapanikolaouCharalampos KossyvakisDimitrios PlatogiannisPublished in: European heart journal. Case reports (2021)
Treatment options of pre-excited AF include anti-arrhythmic agents but mainly electrical cardioversion. Cardioversion can safely restore sinus rhythm, while use of anti-arrhythmics often requires intensive care unit monitoring due to the risk of QT prolongation. Catheter ablation is the mainstay of therapy for symptomatic patients. Our rare report highlights the direct impact of propafenone on prolonging the refractoriness of the AP, effectively and safely, and reappraises propafenone's worthiness as a protective measure following pre-excited AF episode until ablation.
Keyphrases
- atrial fibrillation
- catheter ablation
- case report
- left atrial
- left atrial appendage
- oral anticoagulants
- intensive care unit
- direct oral anticoagulants
- heart failure
- end stage renal disease
- newly diagnosed
- percutaneous coronary intervention
- prognostic factors
- drug induced
- transcription factor
- mechanical ventilation
- coronary artery disease
- acute coronary syndrome
- extracorporeal membrane oxygenation